Literature DB >> 3860290

Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma.

M R Young, M Newby, J Meunier.   

Abstract

Lewis lung carcinoma cells (LLC) were isolated and cloned from metastatic lung nodules of C57BL/6 mice or from a cultured parental LLC line. Their dissemination abilities were defined in vivo by their capacities to disseminate to the lungs following s.c. or i.v. injection into mice and in an in vitro model for tumor dissemination by their ability to migrate out of glass capillary tubes. Cloned LLC cells with an enhanced dissemination capacity exhibited a rounded morphology, were nonadherent during in vitro culture, and readily migrated out of capillary tubes. In contrast, clones not capable of dissemination were adherent and spread during in vitro culture and did not migrate out of capillary tubes. Production of prostaglandin E2 by these clones was measured by a radioimmunoassay. An inverse relationship was observed between the extent of migration and dissemination of clones and their ability to secrete prostaglandin E2 in vitro and in vivo. However, the prostaglandin E2 did not regulate the migration-dissemination capacities of LLC clones as inhibiting prostaglandin synthesis did not alter their capacity to migrate in vitro or to lodge in the lungs following i.v. inoculation into mice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860290

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  Modification of the metastatic potential of tumor cells by drugs.

Authors:  K Takenaga
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 2.  Perspectives in the treatment of cancer metastasis.

Authors:  S Garattini
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

Review 3.  Cell-contact and -architecture of malignant cells and their relationship to metastasis.

Authors:  A Raz; A Ben-Ze'ev
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Influence of lipid diets on the number of metastases and ganglioside content of H59 variant tumors.

Authors:  J Coulombe; G Pelletier; P Tremblay; G Mercier; D Oth
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.

Authors:  M R Young; M A Wright; M E Young
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Oscillating activity of a Ca(2+)-sensitive K+ channel. A prerequisite for migration of transformed Madin-Darby canine kidney focus cells.

Authors:  A Schwab; L Wojnowski; K Gabriel; H Oberleithner
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Characterization of Lewis lung clonal variants in a model of syngeneic pulmonary murine metastases.

Authors:  Bill T Storey; H Keith Pittman; Joseph F Christian; Carl E Haisch; Kathryn M Verbanac
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants.

Authors:  Jodi L Jackson; M Rita I Young
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Substrate adhesiveness and experimental metastatic potential of rat ascites hepatoma AH7974-derived variant sublines.

Authors:  T Kawaguchi; S Igarashi; H Wakabayashi; S Yokoya; K Fukui
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

10.  Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.

Authors:  B A Teicher; T T Korbut; K Menon; S A Holden; G Ara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.